News

CNAT

What Mistakes to Avoid When Playing Biotech

The Life Sciences Report | Equities.com |

The stock market volatility is causing some investors to rethink their biotech investments.


7 Micro-Cap Biotech Stocks with Massive Potential

The Life Sciences Report | Equities.com |

Biotechnology can be daunting to comprehend, but understanding is critical to successful investment. BioWatch News Founder Alan Leong has a nose for growth names, and his goal is to make their


Biotech Stocks With Considerable Upside Potential

The Life Sciences Report | Equities.com |

Everybody knows that biotech ideas can become huge gainers for investors, but understanding the technology platforms, the unmet needs and the valuations can be daunting, especially in spaces where


Conatus (CNAT) Surges Amid Hepatitis C Fervor

Remy Merritt | Equities.com |

Conatus Pharmaceuticals (CNAT) continues the trend of huge pharmaceutical and biotechnology movers this week, peaking on June 11 at an intraday high of $9.87 a share. The past week has seen huge


26th Annual ROTH Conference Opens with Panel Discussion on Affordable Care Act

Joel Anderson | Equities.com |

The 26th Annual ROTH Conference kicked off on Sunday with a panel presentation exploring how the health care industry might be affected by the Affordable Care Act. While not a subject that’s


Intercept Pharmaceuticals (ICPT) Sees Pullback from Record Gains

Joel Anderson | Equities.com |

Intercept Pharmaceuticals (ICPT) continued its wild, roller-coaster ride on Tuesday, with a second-straight day of major losses. Intercept made news last week after its treatment for fatty liver


Intercept Pharmaceuticals (ICPT) Continues to Soar

Joel Anderson | Equities.com |

Shares in biopharmaceutical company Intercept Pharmaceuticals (ICPT) spiked over 70 percent Friday before pulling pack to gains of around 60 percent, one day after shares soared more than 280


DJIA, NASDAQ Edge Lower as S&P Gains on Financials and Services

Michael Teague | Equities.com |

Stocks were mostly lower at the conclusion of Thursday’s trading session, as Wall Street braces itself for what could be more good economic data in the form of Friday’s December jobs


IPO Report: Conatus Pharmaceuticals (CNAT)

Francis Gaskins | Equities.com |

Update:  7-23, hot sector, worth a shot on the IPO Based in San Diego, CA, Conatus Pharmaceuticals (CNAT) scheduled a $55 million IPO with a market capitalization of $161 million at a price


Sequester Looms, Does Anyone Care?

George Brooks | Equities.com |

Congress returns today to face the sequester deadline, a mere 10 days away. Automatic spending cuts of $85 billion through September 30 are expected to kick in at varying times after March 1, if


Watchlist

Symbol Last Price Change % Change
AAPL

     
AMZN

     
HD

     
JPM

     
IBM

     

Can the Media Solve the Partisan Conflict?

Andrew McCarthy, Contributing Editor, The National Review; Michael Zeldin, CNN Legal Analyst; Celeste Katz, Senior Political Reporter, Glamour; Silvia Davi, SVP, Contributing Editor, Equities.com; and Doug Simon, CEO, D S Simon Media discuss how the media’s role has shaped the landscape for communicators and what the media is trying to do to reduce discord in society.